Loading clinical trials...
Loading clinical trials...
Randomized Double-Blind Vehicle-Controlled Study of the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Conditions
Interventions
SM-020 gel 1.0%
Vehicle gel
Locations
4
United States
Driven Research LLC
Coral Gables, Florida, United States
Minnesota Clinical Study Center
New Brighton, Minnesota, United States
Oregon Medical Research Center
Portland, Oregon, United States
Oregon Dermatology and Research Center
Portland, Oregon, United States
Start Date
November 6, 2023
Primary Completion Date
September 15, 2024
Completion Date
October 15, 2024
Last Updated
May 10, 2024
NCT07441538
NCT04249115
NCT03846531
NCT00540566
NCT03487588
NCT01986920
Lead Sponsor
DermBiont, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions